Furthermore, we show the potential in using this QSP model as an in silico evaluation tool to explore different combination regimens, including various RT doses and fractionation schedules, and in various sequencing with PD-L1 blockade, in order to maximize anti-tumor responses. Here, CD274 is linked to neoplasm.